Latest kidney cancer news
Multi-million-pound UK-wide research into cancer immunotherapy
The Francis Crick Institute and The Royal Marsden NHS Foundation [...]
ASTRO 2024: SABR for primary kidney cancer – Is it ready for ‘primetime’?
In this presentation at the 2024 American Society for Radiation [...]
Clinical impact of the CARMENA trial on cytoreductive nephrectomy in the USA
A recent study looked at whether the use of cytoreductive [...]
Kidney Cancer Highlights from ESMO 2024
This year’s European Society for Medical Oncology (ESMO) Congress was [...]
Pazopanib plus bevacizumab shows promise as a first-line treatment for kidney cancer
Results from a phase 2 study of pazopanib alternated with [...]
Biopsy of small renal masses leads to fewer radical nephrectomies
This study looks at how how the biopsy of small [...]
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo sunitinib Sutent cabozantinib progression-free survival NHS England biomarkers kidney cancer ipilimumab Cabometyx pembrolizumab COVID-19 axitinib cancer survival non-clear cell kidney cancer VEGF inhibitors Inlyta coronavirus Yervoy risk factors adjuvant therapy Keytruda metastases targeted therapy everolimus papillary RCC biological markers Afinitor cancer outcomes ASCO first-line treatment NICEArchives
- 2024: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec